Abnormal uterine bleeding during progestin-only contraception may result from free radical-induced alterations in angiopoietin expression

American Journal of Pathology

Volumn 161, Issue 3, 2002, Pages 979-986

  Krikun, Graciela ^a   Critchley, Hilary ^b   Schatz, Frederick ^a   Wan, Livia ^a   Caze, Rebeca ^a   Baergen, Rebecca N ^c   Lockwood, Charles J ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ESTRADIOL; FREE RADICAL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL HYPOXIA; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NORMAL HUMAN; ORAL CONTRACEPTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; UTERUS BLEEDING;

EID: 0036735291     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64258-7     Document Type: Article

References (40)

1. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery
2. A longitudinal study of changes in endometrial microvascular density in Norplant implant users
3. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel
4. Endometrial morphology during the normal cycle and under the influence of contraceptive steroids
5. Effects of norplant on endometrial tissue factor expression and vessel structure
6. Ovarian steroid and cytokine modulation of human endometrial angiogenesis
7. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium
8. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium
9. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
10. Vascular-specific growth factors and blood vessel
11. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
12. Hypoxia and vascular endothelial growth factor selectively up-regulate angio-poietin-2 in bovine microvascular endothelial cells
13. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia
14. The measurement of endometrial perfusion in Norplant users: A pilot study
15. Expression of angiopoietin-2 by human endometrial endothelial cells: Regulation by hypoxia and inflammation
16. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia
17. Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: Potential relevance to menstruation and endometrial regeneration
18. Oxidative stress: Animal adaptations in nature
19. Antioxidants in critical illness
20. New developments in the treatment of ischemia/reperfusion injury
21. Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma
22. Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes
23. Hypoxia-reoxygenation differentially stimulates stress-activated protein kinases in primary-cultured rat hepatocytes
24. Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia
25. Oxidative stress, vitamin E and progestin breakthrough bleeding
26. Dating the endometrial biopsy
27. Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3
28. Progestin-epidermal growth factor regulation of tissue factor expression during decidualization of human endometrial stromal cells
29. Human endometrial endothelial cells: Isolation, characterization, an inflammatory-mediated expression of tissue factor and type 1 plasminogen activator inhibitor
30. Tumor necrosis factor-alpha upregulates angiopoietin-2 in human umbilical endothelial
31. Stereochemical studies on the cytochrome P-450 and hydroxyl radical dependent pathways of 2-butanol oxidation by microsomes from chow-fed, phenobarbital-treated, and ethanol-treated rats
32. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors
33. Do endothelial cells of human endometrial microvessels express estrogen receptors?
34. Spatially regulated differentiation of endometrial vascular smooth muscle cells
35. An update on the role of free radicals and antioxidant defense in human disease
36. Oxygen radicals in the adult respiratory distress syndrome, in myocardial ischemia and reperfusion injury, and in cerebral vascular damage
37. Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis
38. Brain iron pathways and their relevance to Parkinson's disease
39. The Haber-Weiss reaction and mechanisms of toxicity
40. Calcium signaling and oxidant stress in the vasculature